Stock listing

Ideaya Biosciences, Inc.

Selected listing: IDYA · BOATS · USD · US

Ideaya Biosciences, Inc. (BOATS:IDYA), Health Technology. Latest release Sep 28, 2026: IDEAYA Biosciences Announces the Promotion of Dr. Michael White…

IDYA:BOATSUSDUSUpdated October 2, 2026

Ticker: BOATS:IDYA
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: BOATS
Currency: USD

About Ideaya Biosciences, Inc.

Ideaya Biosciences, Inc. (Ticker: IDYA) is a public company operating in the American market, focusing on the development of targeted therapies for cancer and other diseases. Ideaya is dedicated to advancing its innovative drug candidates through clinical development to address unmet medical needs.

Latest news from Ideaya Biosciences, Inc.

IDEAYA Biosciences Announces the Promotion of Dr. Michael White to President, Research and Development

September 28, 2026

IDEAYA Biosciences and Servier Announce First Patient Dosed in OptimUM-11 Global Phase 3 Registrational Trial of Darovasertib and Crizotinib as Adjuvant Therapy for Subjects with Uveal Melanoma

September 9, 2026

IDEAYA Biosciences Announces London Investor R&D Day and Participation in Upcoming September 2026 Investor Conferences

September 1, 2026

IDEAYA Biosciences Announces Successful FDA Type C Meeting for IDE849, DLL3 TOP1 ADC, on Phase 3 Registrational Trial Design for Potential Accelerated and Full Approval in Extensive Stage Small Cell Lung Cancer

August 31, 2026

IDEAYA Biosciences Announces Clinical Collaboration with Genentech in MTAP-Deleted KRAS G12D-Mutant Pancreatic Cancer

August 19, 2026

All Ideaya Biosciences, Inc. news →

Research Ideaya Biosciences, Inc.

Ideaya Biosciences, Inc. company profile

View the public company page for Ideaya Biosciences, Inc. on 6ix.

Ideaya Biosciences, Inc. news

Read company news and market updates connected to Ideaya Biosciences, Inc..

Ideaya Biosciences, Inc. investor events

Find investor webinars, events, and replay context for Ideaya Biosciences, Inc..